Determining whether your product is a veterinary health product or drug in Canada is one of the first and most consequential decisions you will make before entering the
... Read more
If you hold a cannabis licence in Canada, you’ve likely come across the acronyms GMP, GPP, and GACP. They’re not interchangeable, and mixing them up
... Read more
If your organization sells finished medical devices in the United States, the structure of your medical device QMS is no longer governed by the Quality
... Read more
Standard operating procedures for cannabis retail business operations are not optional extras. They are foundational documents that provincial regulators expect you to have in place
... Read more
If you manage regulatory submissions for natural health products, you likely already know that Health Canada ends FSRN acceptance as of February 16, 2026. Health Canada announced this change through Natural Health Products Site Licensing and Good Manufacturing Practices Inspection Bulletin No. 10.
... Read more
Health Canada is moving to answer a question the industry has been pressing for years: why should Canada conduct a full independent review of a
... Read more
Missing your MDEL renewal deadline puts your entire Canadian market access at risk. Under the Medical Devices Regulations (SOR/98-282), all Medical Device Establishment Licence holders must complete their Annual Licence Review
... Read more
In a letter issued February 5, 2026, the U.S. Food and Drug Administration (FDA) said it intends to exercise enforcement discretion when food manufacturers use
... Read more
Health Canada has opened a public consultation on a new prebiotics monograph, with stakeholder feedback accepted until February 20, 2026. The draft guidance, released by the
... Read more
Health Canada has confirmed that Sports Electrolyte Supplements will be reclassified under a single regulatory framework, marking a significant change for products currently regulated as either natural
... Read more
On January 23, 2026, the U.S. Food and Drug Administration (FDA) announced new actions aimed at improving how a gluten ingredient is disclosed on food labels. The update, released on January
... Read more
The U.S. Food and Drug Administration (FDA) has released its priority deliverables for 2026 under the Human Food Program, outlining where the agency plans to
... Read more
